Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
Journal article
Michael S. et al, (2020), Practical Neurology
Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms
Journal article
Ramberger M. et al, (2020), Brain, 143, 1731 - 1745
Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
Conference paper
Binks S. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 77 - 77
Real-world prevalence of autoantibodies in epilepsy
Conference paper
McGinty RN. et al, (2020), EUROPEAN JOURNAL OF NEUROLOGY, 27, 61 - 61
Intrathecal B cell activation in LGI1-antibody encephalitis
Journal article
lehmann-horn K. et al, (2019), Neurology: Neuroimmunology & Neuroinflammation.
CXCL13 LEVELS AND AUTOANTIBODY EPITOPE SPECIFICITIES IN LGI1-AUTOANTIBODY SYNDROMES
Conference paper
Michael S. et al, (2019), JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 90, E34 - E35
CXCL13 Levels in LGI1-and CASPR2-autoantibody syndromes
Conference paper
Michael S. et al, (2019), EUROPEAN JOURNAL OF NEUROLOGY, 26, 265 - 265
Immunophenotyping of autoimmune epilepsy by mass cytometry
Conference paper
McGinty RN. et al, (2019), *JournalName*, 26, 135 - 135
Seronegative antibody-mediated neurology after immune checkpoint inhibitors
Journal article
Wilson R. et al, (2018), Annals of Clinical and Translational Neurology, 5, 640 - 645
A practical guide to the use of anti-epileptic drugs by neurosurgeons
Journal article
Afshari FT. et al, (2017), British Journal of Neurosurgery, 31, 551 - 556
Severe but reversible neuropathy and encephalopathy due to vitamin E deficiency
Journal article
Wysota B. et al, (2017), Clinical Neurology and Neurosurgery, 160, 19 - 20